Mario Mietzsch

Mario Mietzsch,

AST SCTST

Department: MD-BIOCHEM / MOLECULAR BIOL
Business Phone: (352) 846-1836
Business Email: mario.mietzsch@ufl.edu

Teaching Profile

Courses Taught
2020-2022
GMS6251 Molecular Therapy I – Vectors and Molecular Mechanisms
2021
BCH6747 Structural Biology/Advanced Physical Biochemistry: Spectroscopy and Hydrodynamics
2021-2025
BCH6740 Physical Biochemistry/Structural Biology

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0001-8957-3363

Publications

Academic Articles
2025
Biophysical and structural insights into AAV genome ejection.
Journal of virology. 99(3) [DOI] 10.1128/jvi.00899-24. [PMID] 39907279.
2025
Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased α-Catenin.
The Prostate. 85(2):156-164 [DOI] 10.1002/pros.24812. [PMID] 39428693.
2025
Structural Capsidomics of Single-Stranded DNA Viruses
Viruses. 17(3) [DOI] 10.3390/v17030333.
2025
The Structural, Biophysical, and Antigenic Characterization of the Goose Parvovirus Capsid
Microorganisms. 13(1) [DOI] 10.3390/microorganisms13010080. [PMID] 39858848.
2024
Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19
Biomolecular NMR Assignments. 18(2):147-152 [DOI] 10.1007/s12104-024-10181-7.
2024
Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19.
Research square. [DOI] 10.21203/rs.3.rs-4441481/v1. [PMID] 38883784.
2024
Disruption of the Physical Interaction Between Carbonic Anhydrase IX and the Monocarboxylate Transporter 4 Impacts Lactate Transport in Breast Cancer Cells
International Journal of Molecular Sciences. 25(22) [DOI] 10.3390/ijms252211994. [PMID] 39596062.
2024
Dissecting positive selection events and immunological drives during the evolution of adeno-associated virus lineages.
PLoS pathogens. 20(6) [DOI] 10.1371/journal.ppat.1012260. [PMID] 38885242.
2024
Genome-Wide Transcriptional Roles of KSHV Viral Interferon Regulatory Factors in Oral Epithelial Cells
Viruses. 16(6) [DOI] 10.3390/v16060846. [PMID] 38932139.
2024
Hyperacetylation mimetics within the tau filament core inhibits prion-like propagation of misfolded tau.
bioRxiv : the preprint server for biology. [DOI] 10.1101/2024.04.12.589253. [PMID] 38659970.
2024
Maize Streak Virus: Single and Gemini Capsid Architecture
Viruses. 16(12) [DOI] 10.3390/v16121861. [PMID] 39772173.
2024
Overcoming resolution attenuation during tilted cryo-EM data collection.
Nature communications. 15(1) [DOI] 10.1038/s41467-023-44555-7. [PMID] 38195598.
2024
Structural characterization and epitope mapping of the AAVX affinity purification ligand
Molecular Therapy – Methods & Clinical Development. 32(4) [DOI] 10.1016/j.omtm.2024.101377. [PMID] 39677563.
2024
Structural characterization of antibody-responses from Zolgensma treatment provides the blueprint for the engineering of an AAV capsid suitable for redosing.
bioRxiv : the preprint server for biology. [DOI] 10.1101/2024.05.01.590489. [PMID] 38746165.
2024
Structural Characterization of Human Bufavirus 1: Receptor Binding and Endosomal pH-Induced Changes
Viruses. 16(8) [DOI] 10.3390/v16081258. [PMID] 39205232.
2024
The Structure of Spiroplasma Virus 4: Exploring the Capsid Diversity of the Microviridae
Viruses. 16(7) [DOI] 10.3390/v16071103. [PMID] 39066266.
2023
Development of new adeno-associated virus capsid variants for targeted gene delivery to human cardiomyocytes.
Molecular therapy. Methods & clinical development. 30:459-473 [DOI] 10.1016/j.omtm.2023.08.010. [PMID] 37674904.
2023
Editorial: Parvoviruses: from basic research to biomedical and biotechnological applications.
Frontiers in microbiology. 14 [DOI] 10.3389/fmicb.2023.1194926. [PMID] 37256056.
2023
Overcoming Resolution Attenuation During Tilted Cryo-EM Data Collection.
bioRxiv : the preprint server for biology. [DOI] 10.1101/2023.07.14.548955. [PMID] 37503021.
2023
Production and characterization of an AAV1-VP3-only capsid: An analytical benchmark standard.
Molecular therapy. Methods & clinical development. 29:460-472 [DOI] 10.1016/j.omtm.2023.05.002. [PMID] 37273903.
2023
Structural and antigenic characterization of the avian adeno-associated virus capsid.
Journal of virology. 97(10) [DOI] 10.1128/jvi.00780-23. [PMID] 37702486.
2023
Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants.
Journal of virology. 97(7) [DOI] 10.1128/jvi.01772-22. [PMID] 37310260.
2023
Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy. 31(7):1979-1993 [DOI] 10.1016/j.ymthe.2023.03.032. [PMID] 37012705.
2023
Structural Characterization of Canine Minute Virus, Rat and Porcine Bocavirus
Viruses. 15(9) [DOI] 10.3390/v15091799. [PMID] 37766206.
2022
Capsid Structure of Aleutian Mink Disease Virus and Human Parvovirus 4: New Faces in the Parvovirus Family Portrait.
Viruses. 14(10) [DOI] 10.3390/v14102219. [PMID] 36298773.
2022
Characterization of the Serpentine Adeno-Associated Virus (SAAV) Capsid Structure: Receptor Interactions and Antigenicity.
Journal of virology. 96(11) [DOI] 10.1128/jvi.00335-22. [PMID] 35532224.
2022
Structural characterization of an envelope-associated adeno-associated virus type 2 capsid.
Virology. 565:22-28 [DOI] 10.1016/j.virol.2021.09.010. [PMID] 34638006.
2022
Structurally Mapping Antigenic Epitopes of Adeno-associated Virus 9: Development of Antibody Escape Variants.
Journal of virology. 96(3) [DOI] 10.1128/JVI.01251-21. [PMID] 34757842.
2021
Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly.
Journal of virology. 95(7) [DOI] 10.1128/JVI.02023-20. [PMID] 33441336.
2021
Characterization of the GBoV1 Capsid and Its Antibody Interactions.
Viruses. 13(2) [DOI] 10.3390/v13020330. [PMID] 33672786.
2021
Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2.
Journal of structural biology. 213(4) [DOI] 10.1016/j.jsb.2021.107795. [PMID] 34509611.
2021
Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features.
Viruses. 13(1) [DOI] 10.3390/v13010101. [PMID] 33450892.
2021
Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
Journal of virology. 95(19) [DOI] 10.1128/JVI.00773-21. [PMID] 34287038.
2021
Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family.
Viral immunology. 34(1):3-17 [DOI] 10.1089/vim.2020.0022. [PMID] 32315582.
2021
pH-Induced Conformational Changes of Human Bocavirus Capsids.
Journal of virology. 95(8) [DOI] 10.1128/JVI.02329-20. [PMID] 33472934.
2021
Receptor Switching in Newly Evolved Adeno-associated Viruses.
Journal of virology. 95(19) [DOI] 10.1128/JVI.00587-21. [PMID] 34232726.
2021
Structural Study of Aavrh.10 Receptor and Antibody Interactions.
Journal of virology. 95(23) [DOI] 10.1128/JVI.01249-21. [PMID] 34549984.
2020
Adeno-Associated Virus (AAV) Capsid Stability and Liposome Remodeling During Endo/Lysosomal pH Trafficking.
Viruses. 12(6) [DOI] 10.3390/v12060668. [PMID] 32575696.
2020
Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies.
Molecular therapy. Methods & clinical development. 19:362-373 [DOI] 10.1016/j.omtm.2020.10.001. [PMID] 33145372.
2020
Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach.
Journal of virology. 94(19) [DOI] 10.1128/JVI.00976-20. [PMID] 32669336.
2020
Comparative Analysis of the Capsid Structures of AAVrh.10, AAVrh.39, and AAV8.
Journal of virology. 94(6) [DOI] 10.1128/JVI.01769-19. [PMID] 31826994.
2020
Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing.
Molecular therapy. Nucleic acids. 20:451-458 [DOI] 10.1016/j.omtn.2020.03.009. [PMID] 32276210.
2020
Impact of Natural or Synthetic Singletons in the Capsid of Human Bocavirus 1 on Particle Infectivity and Immunoreactivity.
Journal of virology. 94(11) [DOI] 10.1128/JVI.00170-20. [PMID] 32213611.
2020
Structural characterization of a bat Adeno-associated virus capsid.
Journal of structural biology. 211(2) [DOI] 10.1016/j.jsb.2020.107547. [PMID] 32522552.
2020
Structural Characterization of Cuta- and Tusavirus: Insight into Protoparvoviruses Capsid Morphology.
Viruses. 12(6) [DOI] 10.3390/v12060653. [PMID] 32560452.
2019
Dynorphin-based “release on demand” gene therapy for drug-resistant temporal lobe epilepsy.
EMBO molecular medicine. 11(10) [DOI] 10.15252/emmm.201809963. [PMID] 31486590.
2019
High-Resolution Structural Characterization of a New Adeno-associated Virus Serotype 5 Antibody Epitope toward Engineering Antibody-Resistant Recombinant Gene Delivery Vectors.
Journal of virology. 93(1) [DOI] 10.1128/JVI.01394-18. [PMID] 30333169.
2019
ICTV Virus Taxonomy Profile: Parvoviridae.
The Journal of general virology. 100(3):367-368 [DOI] 10.1099/jgv.0.001212. [PMID] 30672729.
2019
Twenty-Five Years of Structural Parvovirology.
Viruses. 11(4) [DOI] 10.3390/v11040362. [PMID] 31010002.
2018
Atomic Resolution Structures of Human Bufaviruses Determined by Cryo-Electron Microscopy.
Viruses. 10(1) [DOI] 10.3390/v10010022. [PMID] 29300333.
2018
Atomic structure of a rationally engineered gene delivery vector, AAV2.5.
Journal of structural biology. 203(3):236-241 [DOI] 10.1016/j.jsb.2018.05.004. [PMID] 29775653.
2018
CART neurons in the arcuate nucleus and lateral hypothalamic area exert differential controls on energy homeostasis.
Molecular metabolism. 7:102-118 [DOI] 10.1016/j.molmet.2017.10.015. [PMID] 29146410.
2018
Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant.
Nature communications. 9(1) [DOI] 10.1038/s41467-018-06076-6. [PMID] 30194371.
2017
Direct Head-to-Head Evaluation of Recombinant Adeno-associated Viral Vectors Manufactured in Human versus Insect Cells.
Molecular therapy : the journal of the American Society of Gene Therapy. 25(12):2661-2675 [DOI] 10.1016/j.ymthe.2017.08.003. [PMID] 28890324.
2017
OneBac 2.0: Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA.
Human gene therapy methods. 28(1):15-22 [DOI] 10.1089/hgtb.2016.164. [PMID] 28125901.
2017
Structural Insights into Human Bocaparvoviruses.
Journal of virology. 91(11) [DOI] 10.1128/JVI.00261-17. [PMID] 28331084.
2017
The Good That Viruses Do.
Annual review of virology. 4(1):iii-v [DOI] 10.1146/annurev-vi-04-071217-100011. [PMID] 28961414.
2017
Thermal Stability as a Determinant of AAV Serotype Identity.
Molecular therapy. Methods & clinical development. 6:171-182 [DOI] 10.1016/j.omtm.2017.07.003. [PMID] 28828392.
2017
Understanding capsid assembly and genome packaging for adeno-associated viruses.
Future virology. 12(6):283-297 [DOI] 10.2217/fvl-2017-0011. [PMID] 36776482.
2016
A Comprehensive RNA Sequencing Analysis of the Adeno-Associated Virus (AAV) Type 2 Transcriptome Reveals Novel AAV Transcripts, Splice Variants, and Derived Proteins.
Journal of virology. 90(3):1278-89 [DOI] 10.1128/JVI.02750-15. [PMID] 26559843.
2016
Comprehensive Small RNA-Seq of Adeno-Associated Virus (AAV)-Infected Human Cells Detects Patterns of Novel, Non-Coding AAV RNAs in the Absence of Cellular miRNA Regulation.
PloS one. 11(9) [DOI] 10.1371/journal.pone.0161454. [PMID] 27611072.
2015
NPY Y2 receptors in the central amygdala reduce cued but not contextual fear.
Neuropharmacology. 99:665-74 [DOI] 10.1016/j.neuropharm.2015.08.038. [PMID] 26314208.
2015
OneBac 2.0: Sf9 Cell Lines for Production of AAV5 Vectors with Enhanced Infectivity and Minimal Encapsidation of Foreign DNA.
Human gene therapy. 26(10):688-97 [DOI] 10.1089/hum.2015.050. [PMID] 26134901.
2014
A simplified purification protocol for recombinant adeno-associated virus vectors.
Molecular therapy. Methods & clinical development. 1 [DOI] 10.1038/mtm.2014.34. [PMID] 26015974.
2014
Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans.
Journal of virology. 88(5):2991-3003 [DOI] 10.1128/JVI.03371-13. [PMID] 24371066.
2014
OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.
Human gene therapy. 25(3):212-22 [DOI] 10.1089/hum.2013.184. [PMID] 24299301.
2013
Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN.
Cell metabolism. 17(2):236-48 [DOI] 10.1016/j.cmet.2013.01.006. [PMID] 23395170.
2012
DNA-binding activity of adeno-associated virus Rep is required for inverted terminal repeat-dependent complex formation with herpes simplex virus ICP8.
Journal of virology. 86(5):2859-63 [DOI] 10.1128/JVI.06364-11. [PMID] 22205745.

Grants

Sep 2024 ACTIVE
Engineering AAV for safe and efficient gene delivery to the human retina
Role: Co-Investigator
Funding: NATL INST OF HLTH NEI
May 2024 ACTIVE
AAV capsids and their cellular interactions
Role: Co-Investigator
Funding: NATL INST OF HLTH NIGMS
Apr 2024 – Apr 2024
Structural characterization of AAV capsid ligand complexes
Role: Co-Project Director/Principal Investigator
Funding: AVITIDE
Jan 2024 – Jan 2024
Structural characterization of AAV capsid ligand complexes
Role: Co-Project Director/Principal Investigator
Funding: AVITIDE
Jan 2024 ACTIVE
A modified arrestin1 to enhance glycolysis in photoreceptors as a therapeutic approach to slowing retinal degeneration
Role: Co-Investigator
Funding: NATL INST OF HLTH NEI
Jan 2024 ACTIVE
Leaving no child behind: enabling universal access to AAV gene therapies by vector bio-engineering to evade pre-existing natural immunity
Role: Co-Project Director/Principal Investigator
Funding: CHILDRENS MEDICAL RESEARCH INSTITUTE via NATL HEALTH AND MED RESEARCH COUNCIL
Nov 2022 – Oct 2023
A study into the expression of TTV and its possible development as a gene therapy vector
Role: Co-Investigator
Funding: INTIMA BIOSCIENCE
Feb 2022 – Jul 2022
Cryo-EM analysis of AAV capsid full/empty ratio determinations
Role: Co-Investigator
Funding: STRIDEBIO
Dec 2021 – Jan 2022
Generation of AAV1 VP3-only DNA empty capsids
Role: Co-Investigator
Funding: THERMO FINNIGAN
Aug 2021 – Oct 2021
Generation of AAV1 VP3 only DNA empty capsids
Role: Co-Investigator
Funding: THERMO FINNIGAN
Jun 2018 – Apr 2022
A role for AAV Rep in genome packaging efficiency
Role: Co-Investigator
Funding: INTIMA BIOSCIENCE
Jan 2017 – May 2022
AAV1 Variants for CNS Targeted Therapies
Role: Co-Investigator
Funding: VOYAGER THERAPEUTICS INC

Contact Details

Phones:
Business:
(352) 846-1836
Emails:
Addresses:
Business Mailing:
PO BOX 100245
DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIO
GAINESVILLE FL 326100245